Bioxiness Pharmaceuticals
Hercules
About Bioxiness Pharmaceuticals
Bioxiness Pharmaceuticals is a California-based pre-clinical stage company, developing a novel class of antimicrobial compounds for the treatment of severe bacterial infections. Bioxiness compounds are new chemical class (NCC) developed towards critical target-enzymes within the pathogenic bacterial cells. These molecules employ unique mode of antimicrobial actions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $804.6K
- Last round: Convertible Note (Sep 2016)
- Website: bioxiness.com
- Phone: 5102635624
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/bioxiness-pharmaceuticals-151468 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.